Pliant Therapeutics CMO Éric Lefebvre to depart on Dec 15, 2025

PLIANT THERAPEUTICS, INC.

Chief Medical Officer Éric Lefebvre's employment terminates effective Dec 15, 2025.
Lefebvre expected to assist as consultant post-Separation Date for transition support.
No immediate replacement for CMO role announced by the Company.

item 5.02

PLIANT THERAPEUTICS, INC. filing history →

Source: SEC EDGAR

accession 0001746473-25-000179

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.